Symphogen

📍 Ballerup, Denmark🗓 Founded 2000👥 181 employees💰 Last funded Dec 2011
Biotechnology Research🌐 symphogen.com
Website LinkedIn
Symphogen A/S, a Servier company and the Centre of Excellence for Antibodies, operates within in research, early clinical stages and CMC biologics development from research to market. Supporting Servier’s commitment to improve patients health and the R&D strategy within oncology and immune-oncology - Symphogen’s strategic focus is to apply our streamlined and effective antibody platform and capabilities in the discovery and early development of highly differentiated antibodies. The aim is to develop novel compounds either as combination or as stand-alone therapies for difficult to treat cancers.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
2000
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Netherlands
1
Frequently asked questions
Who invested in Symphogen?
Symphogen has 1 investors on record on gritt.io.
When did Symphogen last raise funding?
The most recent investment in Symphogen recorded on gritt.io was in December 2011.
When was Symphogen founded?
Symphogen was founded in 2000.
What industry is Symphogen in?
Symphogen operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Symphogen based?
Symphogen is headquartered in Ballerup, Denmark.